Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Novo Holdings A/S Create: Alert

All | News | Filings
Date FiledTypeDescription
12/30/2020 SC 13G/A Novo Holdings A/S reports a 4.8% stake in SeaSpine Holdings Corp
12/18/2020 SC 13D/A Novo Holdings A/S reports a 8.4% stake in Mirum Pharmaceuticals, Inc.
11/16/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/05/2020 SC 13D Novo Holdings A/S reports a 10.2% stake in GALECTO, INC.
11/04/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Galecto, Inc.
Txns: Converted 2,164,458 shares @ $0
Bought 333,333 shares @ $15, valued at $5M
Converted 25,562 preferred shares @ $0
Converted 15,833 preferred shares @ $0
Converted 63,333 options to buy @ $0
Converted 66,666 options to buy @ $0
Converted 133,991 preferred shares @ $0
Converted 194,666 preferred shares @ $0
Converted 181,688 options to buy @ $0
Converted 51,911 options to buy @ $0
Converted 98,930 preferred shares @ $0
10/28/2020 3 Novo Holdings A/S (10% Owner) has filed a Form 3 on Galecto Inc.
10/22/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Eargo, Inc.
Txns: Converted 737,071 shares @ $0
Bought 150,000 shares @ $18, valued at $2.7M
Converted 737,071 convertible preferred @ $0
10/22/2020 SC 13D Novo A/S reports a 7.7% stake in Aligos Therapeutics, Inc.
10/22/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns: Converted 2,414,563 shares @ $0
Bought 200,000 shares @ $15, valued at $3M
Converted 1,609,493 convertible preferred @ $0
Converted 563,851 options to buy @ $0
Converted 241,219 options to buy @ $0
10/21/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 2,442,080 shares @ $0
Converted 4,150,000 options to buy @ $0
Converted 551,794 options to buy @ $0
Converted 171,410 options to buy @ $0
Converted 352,734 options to buy @ $0
10/19/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.
Txns: Sold 450,000 shares @ $11, valued at $5M
10/16/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns: Converted 4,739,336 shares @ $0
Bought 250,000 shares @ $15, valued at $3.8M
Converted 21,000,000 convertible preferred @ $0
Converted 10,000,000 convertible preferred @ $0
10/16/2020 SC 13D Novo A/S reports a 21.5% stake in Spruce Biosciences, Inc.
10/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/08/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
10/05/2020 SC 13D/A Novo A/S reports a 5.4% stake in Verona Pharma plc
10/05/2020 SC 13D/A Novo A/S reports a 11% stake in Inozyme Pharma, Inc.
09/04/2020 4/A Novo Holdings A/S (10% Owner) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Converted 3,622,470 shares @ $0
Converted 25,000,000 convertible preferred @ $0
Converted 1,860,107 convertible preferred @ $0
09/04/2020 3/A Novo Holdings A/S (10% Owner) has filed a Form 3/A on Harmony Biosciences Holdings, Inc.
09/04/2020 SC 13G/A Novo A/S reports a 6.6% stake in Harmony Biosciences Holdings, Inc.
08/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/18/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/14/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/13/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/11/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
07/29/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Converted 2,194,379 shares @ $0
Bought 375,000 shares @ $16, valued at $6M
Converted 15,000,000 convertible preferred @ $0
Converted 1,398,600 convertible preferred @ $0
07/29/2020 SC 13D Novo A/S reports a 11.5% stake in Inozyme Pharma, Inc.
07/24/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy